Physician
Family Medicine
Dr. Anthony Kinsella, MD
|
|
Give Review
Anthony Kinsella, MD practices Family Medicine. Anthony Kinsella is also published. He has 59 publications published. The lastest publication: "p53 protein expression in tumours from head and neck subsites, larynx and hypopharynx, and differences in relationship to survival.' Dr. Anthony Kinsella is registered with Medicare and accepts Medicare payments.
Publications
- Membrane-mediated responses to 12-O-tetradecanoylphorbol-13-acetate in human skin fibroblasts.
- Investigation of the effects of the phorbol ester TPA on carcinogen-induced forward mutagenesis to 6-thioguanine-resistance in V79 Chinese hamster cells.
- Analysis of spontaneous, carcinogen-induced and promoter-induced chromosomal instability in patients with hereditary retinoblastoma.
- Phenotypic resistance to methotrexate and N-phosphonacetyl L-aspartate is induced by treatment with 12-O-tetradecanoylphorbol-13-acetate (TPA).
- Susceptibility of skin fibroblasts from individuals genetically predisposed to cancer, to transformation by the tumour promoter 12-O-tetradecanoylphorbol-13-acetate.
- p53 protein expression in tumours from head and neck subsites, larynx and hypopharynx, and differences in relationship to survival.
- Prodrug-activated gene therapy: involvement of an immunological component in the "bystander effect".
- Prevalence of item level negative symptoms in first episode psychosis diagnoses.
- Can we combine symptom scales for collaborative research projects?
- Mental health literacy among Internet users.
- Suicidality prior to presentation in first-episode psychosis.
- Phenotypic disruption to orofacial movement topography in conditional mutants with generalized CamKIIa/Cre D1Tox versus striatal-specific DARPP-32/Cre D1Tox ablation o...
- First rank symptoms in first episode psychosis and their relationship to the duration of untreated illness.
- Frontonasal dysmorphology in bipolar disorder by 3D laser surface imaging and geometric morphometrics: comparisons with schizophrenia.
- Orofacial movements in phospholipase C-related catalytically inactive protein-1/2 double knockout mice: Effect of the GABAergic agent diazepam and the D(1) dopamine re...
- Nonadherence to medication four years after a first episode of psychosis and associated risk factors.
- Assessment of jaw movements by magnetic sensor in relation to topographies of orofacial behaviour in freely moving rats: Studies with the dopamine D(1)-like receptor a...
- Caregiver psychoeducation for first-episode psychosis.
- Schizophrenia and the city: A review of literature and prospective study of psychosis and urbanicity in Ireland.
- First episode psychosis and the trail to secondary care: help-seeking and health-system delays.
- Are symptoms associated with increased levels of perceived stress in first-episode psychosis?
- Phenotype of spontaneous orofacial dyskinesia in neuregulin-1 ''knockout'' mice.
- Beyond the critical period: longitudinal study of 8-year outcome in first-episode non-affective psychosis.
- Dopamine D1 vs D5 receptor-dependent induction of seizures in relation to DARPP-32, ERK1/2 and GluR1-AMPA signalling.
- A little knowledge: caregiver burden in schizophrenia in Malawi.
- Is the duration of untreated psychosis temporally stable?
- Insight, psychopathology and global functioning in schizophrenia in urban Malawi.
- Is violence at presentation by patients with first-episode psychosis associated with duration of untreated psychosis?
- Caregiver psychoeducation for schizophrenia: is gender important?
- A note on the use of outlier criteria in Ontario laboratory quality control schemes.
- Three-dimensional laser surface imaging and geometric morphometrics resolve frontonasal dysmorphology in schizophrenia.
- Untreated illness and outcome of psychosis.
- Suicidality in first episode psychosis.
- Diagnostic specificity and predictors of neurological soft signs in schizophrenia, bipolar disorder and other psychoses over the first 4 years of illness.
- Facial shape and asymmetry by three-dimensional laser surface scanning covary with cognition in a sexually dimorphic manner.
- Disruption of orofacial movement topographies in congenic mutants with dopamine D5 but not D4 receptor or DARPP-32 transduction ''knockout''.
- Sexually dimorphic changes in the exploratory and habituation profiles of heterozygous neuregulin-1 knockout mice.
- Ethological resolution of behavioral topography and D2-like vs. D1-like agonist responses in congenic D4 dopamine receptor "knockouts": identification of D4:D1-like in...
- Facial surface analysis by 3D laser scanning and geometric morphometrics in relation to sexual dimorphism in cerebral--craniofacial morphogenesis and cognitive function.
- Is craniofacial dysmorpholgy correlated with structural brain anomalies in schizophrenia?
- Epidemiology of first-episode psychosis: illustrating the challenges across diagnostic boundaries through the Cavan-Monaghan study at 8 years.
- Ethological resolution of behavioural topography and D1-like versus D2-like agonist responses in congenic D5 dopamine receptor mutants: identification of D5:D2-like in...
- Neurological soft signs and dermatoglyphic anomalies in twins with schizophrenia.
- Longitudinal assessment of psychopathological domains over late-stage schizophrenia in relation to duration of initially untreated psychosis: 3-year prospective study ...
- Ethologically based resolution of D2-like dopamine receptor agonist-versus antagonist-induced behavioral topography in dopamine- and adenosine 3',5'-monophosphate-regu...
- Obstetric adversity and age at first presentation with schizophrenia: evidence of a dose-response relationship.
- SK&F 83822 distinguishes adenylyl cyclase from phospholipase C-coupled dopamine D1-like receptors: behavioural topography.
- 3D morphometrics of craniofacial dysmorphology reveals sex-specific asymmetries in schizophrenia.
- Schizophrenia, schizoaffective and bipolar disorder within an epidemiologically complete, homogeneous population in rural Ireland: small area variation in rate.
- Redox modulation of integrin [correction of integin] alpha IIb beta 3 involves a novel allosteric regulation of its thiol isomerase activity.
- Comparative phenotypic resolution of spontaneous, D2-like and D1-like agonist-induced orofacial movement topographies in congenic mutants with dopamine D2 vs. D3 recep...
- Compliance therapy: a randomised controlled trial in schizophrenia.
- Essential conservation of D1 mutant phenotype at the level of individual topographies of behaviour in mice lacking both D1 and D3 dopamine receptors.
- Prospective analysis of premature mortality in schizophrenia in relation to health service engagement: a 7.5-year study within an epidemiologically complete, homogeneo...
- Congenic D1A dopamine receptor mutants: ethologically based resolution of behavioural topography indicates genetic background as a determinant of knockout phenotype.
- First-episode schizophrenia, bipolar disorder and other psychoses in a rural Irish catchment area: incidence and gender in the Cavan-Monaghan study at 5 years.
- Phenotypic, ethologically based resolution of spontaneous and D(2)-like vs D(1)-like agonist-induced behavioural topography in mice with congenic D(3) dopamine recepto...
- 3D laser surface scanning and geometric morphometric analysis of craniofacial shape as an index of cerebro-craniofacial morphogenesis: initial application to sexual di...
Doctors Specialties
- Family Medicine
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Blue Care HMO
- Blue Select
- BlueDental Choice
- NetworkBlue
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Carelink HMO
- Employer Group PPO
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Options PPO
Drug Facts
| NPI NUMBER | 1811988785 | |
| NPPES Provider LastName | KINSELLA | |
| NPPES Provider FirstName | ANTHONY | |
| NPPES Provider ZIPCode | 32780 | |
| NPPES Provider State | FL | |
| Specialty Description | Family Practice | |
| Total Claim Count | 5873.0 | |
| Distinct Opioid Count | 11.0 | |
| Opioid Claim Count | 1067.0 | |
| Percent Opioid Claims | 18.17 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1811988785 |
| Last Name Of The Provider | KINSELLA |
| First Name Of The Provider | ANTHONY |
| View All |
Similar Doctors
|
|
Dr. Victor R. Boodhoo, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rodolfo A. Torres Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Luis A. Moreno, MD |
|
|
Dr. John Flaherty, MD |
|
|
Dr. Anita D. Spitz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Natvarlal H. Dalsania, MD |
|
|
Dr. Leonard Vaneaton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amber W. Surber, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leon H. Osmon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Marie T. Muller, ARNP |